BridgeMD
New treatment option for Seroma
Official title Seroma of the Mammary Gland
ClinicalTrials.gov ID: NCT05899387
What this study is testing
- What it's testing
- The study is designed as international, prospective, minimal interventional study in cooperation with EUBREAST e.V. (European Breast Cancer Research Association of Surgical Trialists).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- study group and control group 1:
- Written informed consent
- Age ≥ 18 years
- all stages of DCIS or primary breast cancer (T1-T4, N0 or N+, M0) including all histopathological subtypes (ER/PR positive, ER positive/PR negative...
- Surgical procedure planned including ablatio or subcutaneous mastectomy with implant or expander insertion control group 2 and 3:
You likely can't join if
- Age \<18 years
- Male sex
- Breast cancer patients planned for breast conserving therapy
- Recurrent breast cancer disease
- History of breast surgery
- Diagnosis of LCIS only
See the full eligibility criteria
- study group and control group 1:
- Written informed consent
- Age ≥ 18 years
- all stages of DCIS or primary breast cancer (T1-T4, N0 or N+, M0) including all histopathological subtypes (ER/PR positive, ER positive/PR negative, Her-2/neu positive and triple negative)
- Surgical procedure planned including ablatio or subcutaneous mastectomy with implant or expander insertion control group 2 and 3:
- Written informed consent
- Age ≥ 18 years
- Surgical procedure planned with implant or expander insertion with or without subcutaneous mastectomy
- Age \<18 years
- Male sex
- Breast cancer patients planned for breast conserving therapy
- Recurrent breast cancer disease
- History of breast surgery
- Diagnosis of LCIS only
- Pregnancy at time of diagnosis
- Patients with a known immunodeficiency
The study team makes the final eligibility decision.
Where it's taking place
- Augsburg, Bavaria, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Augsburg, Bavaria, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.